CVE-2023-53734 HIGH

CVE-2023-53734: dawa-pharma-1.0 - SQL Injection via Email Parameter

Vendor Mayurik

Product dawa-pharma

Weakness CWE-89 · SQLi

Published December 4, 2025

Last update April 7, 2026

View on NVD All CVEs

CVSS base score

8.7/10

Attack vector Network

Attack complexity Low

Privileges required None

User interaction None

Confidentiality —

Integrity —

CVSS vector

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N

What the vulnerability does

01Description

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Key dates

02Disclosure timeline

December 4, 2025 CVE published

April 7, 2026 Record updated

External resources

03References

NVD — National Vulnerability Database https://nvd.nist.gov/vuln/detail/CVE-2023-53734 CWE — Common Weakness Enumeration https://cwe.mitre.org/data/definitions/89.html

Related vulnerabilities

04Related CVE

CVE-2018-25380 Joomla Component eXtroForms 2.1.5 SQL Injection via filter parameters CVE-2023-38099 NETGEAR ProSAFE Network Management System getNodesByTopologyMapSearch SQL Injection Remote Code Execution Vulnerability CVE-2020-5292 Time-based blind injection in Leantime CVE-2024-7196 SourceCodester Complaints Report Management System sql injection CVE-2019-25535 Netartmedia PHP Dating Site SQL Injection via loginaction.php